Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTPa) containing vaccines GRADE assessments

GRADE assessment for Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTPa) containing vaccines

Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B vaccine (Vaxelis, DT5aP-hepB-IPV-Hib(PRP-OMP))

Coversheet on evidence assessment by ATAGI using the GRADE framework for DT5aP-hepB-IPV-Hib(PRP-OMP)) in infants aged 6 weeks to 10 years

GRADE assessment for DT5aP-hepB-IPV-Hib(PRP-OMP)

• compared against DT3aP-HBV-IPV-Hib(PRP-TT) (Infanrix hexa) in infants aged 6 weeks to 10 years

ATAGI recommendations

• Use of DT5aP-hepB-IPV-Hib(PRP-OMP) versus DT3aP-HBV-IPV-Hib(PRP-TT) in infants aged 6 weeks to 10 years

Note

These GRADE documents should be read as a supplement to the Australian Immunisation Handbook (Handbook) recommendations.

View the related disease chapter in the Handbook here:

• Diphtheria
• Haemophilus influenzae type b (Hib)
• Hepatitis B
• Pertussis (whooping cough)
• Poliomyelitis
• Tetanus